Courtagen Life Sciences Blog

Courtagen Staff

Courtagen is a privately-held life sciences and molecular information company that converts genomic data into actionable clinical information for the diagnosis of critical pediatric neurological and metabolic disorders. Specifically, Courtagen focuses on mitochondrial disorders, epilepsy, and intellectual disability, including autism spectrum disorders.
Find me on:

Recent Posts

Sun, Surf, and Smiles at Venice Beach THERASurf Event

Posted by Courtagen Staff on Jul 21, 2016 10:47:22 AM

This past Saturday, representatives from Courtagen and Medicinal Genomics joined a team of 35 volunteers at the THERASurf event at Venice Beach in Malibu, CA. More than 80 families participated in the event, enjoying the sun and surf on a beautiful Southern California day. 

Read More

Topics: Courtagen Gives Back

Benefits of Ordering Genetic Testing at the Beginning of the Diagnostic Process

Posted by Courtagen Staff on Jul 14, 2016 2:53:33 PM

There is a longstanding adage in clinical genetics that states, "If a patient has seen as many specialists as they are years or months old, then it is time to refer them to a genetics clinic".

Read More

Topics: Seizure Disorders, Genetic Testing, Developmental Delay

Courtagen Featured in PBS News Hour's Medical Cannabis Story

Posted by Courtagen Staff on Jul 7, 2016 2:00:00 PM

Courtagen Life Sciences was prominently featured in Wednesday's PBS News Hour as part of their story on medical cannabis research.

Read More

Topics: Epilepsy, Genetics, Cannabis

Quick Case: Creatine Supplementation as Treatment for Seizure Disorder

Posted by Courtagen Staff on May 16, 2016 2:48:26 PM

Ngoc Minh Le, M.D., pediatric neurologist and Medical Consultant for Courtagen Life Sciences, presents the case of a 6-year-old patient who presented with global developmental delay, seizures, GI issues, and behavioral problems. Courtagen's epiSEEK® panel revealed a mutation on the SLC6A8 gene that is consistent with Creatine Transporter Deficiency Syndrome. After being placed on high-dose creatine monohydrate, arginine, and glycine, the patient became seizure free and his GI issues improved.

Read More

Topics: Epilepsy, Seizure Disorders, Genetic Testing, Developmental Delay